皮肌炎客观复发的临床特征与危险因素
本研究纳入约翰斯·霍普金斯肌炎中心637例符合2017 EULAR/ACR分类标准的皮肌炎患者,采用Cox比例风险模型分析首次客观复发的特征与危险因素;复发率为5.1/100人年,皮疹最常见,黑种人及诊断时间较短与复发风险增加相关。
要点
- 患者报告的皮疹、乏力等症状超85%符合客观复发定义。
- 黑种人及诊断时间较短是皮肌炎复发的危险因素。
- 客观复发率5.1/100人年,诊断至首次复发平均2.9年。
核心结论
- 在三级中心皮肌炎队列中,患者报告的疾病活动症状常提示客观复发,黑种人和较短诊断时间与复发风险增加相关。
研究设计与样本
- 回顾性队列研究,纳入约翰斯·霍普金斯肌炎中心637例符合2017 EULAR/ACR分类标准的皮肌炎患者,由两名作者审查病历记录症状、检查、实验室、影像及用药变化,采用Cox比例风险模型分析首次复发时间与患者特征的关联。
主要发现
- 复发最常见表现为皮疹(75.7%),其次为肌无力(58.4%)、肺功能检查和/或影像新发/加重(19.0%)及关节炎(12.4%)。
- 报告皮疹、乏力、呼吸困难、关节肿胀、吞咽困难或发热的患者中超过85%符合客观复发定义。
- 发生客观复发的皮肌炎患者中,仅2-5%在复发前后6-24个月内诊断癌症。
- 新诊断患者亚组中26%在随访期间发生至少1次复发,复发率为5.1/100人年,诊断至首次复发平均2.9年(SD 2.3),范围6.2个月至10.8年。
关键数值与推荐
- 客观复发定义为体格检查或辅助检查显示活动性疾病并导致免疫抑制治疗增加。
临床怎么用
- 临床应重视皮肌炎患者报告的皮疹、乏力、呼吸困难、关节肿胀、吞咽困难或发热等症状,因其常提示客观复发。
- 对黑种人及诊断时间较短的患者可考虑加强监测策略。
局限性
- 单中心三级医疗中心队列,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Flares in dermatomyositis (DM) are associated with increased disability, health care utilization, and reduced quality of life. We aim to determine the characteristics and risk factors of flares in patients with DM. METHODS: Patients were included if seen at The Johns Hopkins Myositis Center and fulfilled the 2017 EULAR/ACR Classification Criteria for DM. Two authors reviewed all notes and recorded patient symptoms, exams, labs, imaging findings, and medication changes. Objective flare was defined as active disease on exam or ancillary testing that resulted in an increase in immunosuppressive therapy. Characteristics of patients and flares were summarized using descriptive statistics. We assessed the association between patient characteristics and time to first flare using Cox proportional hazards models. RESULTS: In this study with 637 patients with DM, rash was the most common finding of flare (75.7%), followed by muscle weakness (58.4%), new/worsening findings on lung function tests and/or imaging (19.0%) and arthritis (12.4%). Over 85% of the patients who reported rash, weakness, dyspnea, joint swelling, dysphagia or fever met the definition of objective flare. Black race and shorter time to diagnosis were associated with increased flare risk. Among patients with DM who experienced an objective flare, only 2-5% had a cancer diagnosis within 6-24-months of flare. In a subset of newly diagnosed patients, 26% had ≥1 flare during follow-up. The incidence rate of flares was 5.1 per 100 person-years. The average time between diagnosis and the first flare was 2.9 years (SD 2.3) ranging between 6.2 months and 10.8 years. CONCLUSION: In this tertiary care center cohort of DM patients, patient-reported symptoms of increased disease activity were often indicative of objective flare. We identified Black race and shorter time to diagnosis as risk factors for flare. Understanding these factors can inform clinicians about monitoring strategies and improved patient outcomes.
引用
- Saygin D, Wang XY, Fitzgerald KC, et al. Clinical characteristics and risk factors associated with objective flares in patients with dermatomyositis. Semin Arthritis Rheum. 2026. PMID: 41785525. doi:10.1016/j.semarthrit.2026.152947
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。